Log In
BCIQ
Print this Print this
 

AN5568, SCYX-7158

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOral small molecule benzoxaborole
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationTrypanosome
Indication DetailsTreat human African trypanosomiasis (sleeping sickness)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5,200.0M

$5,200.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/24/2016

$5,200.0M

$5,200.0M

0

Get a free BioCentury trial today